These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 28830436

  • 1. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
    Anyanwagu U, Mamza J, Donnelly R, Idris I.
    Cardiovasc Diabetol; 2017 Aug 22; 16(1):107. PubMed ID: 28830436
    [Abstract] [Full Text] [Related]

  • 2. Effect of adding GLP-1RA on mortality, cardiovascular events, and metabolic outcomes among insulin-treated patients with type 2 diabetes: A large retrospective UK cohort study.
    Anyanwagu U, Mamza J, Donnelly R, Idris I.
    Am Heart J; 2018 Feb 22; 196():18-27. PubMed ID: 29421011
    [Abstract] [Full Text] [Related]

  • 3. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY, Zhou RR, Han S, Wang TS, Wang LQ, Xie XH.
    J Clin Pharm Ther; 2018 Aug 22; 43(4):556-570. PubMed ID: 29733433
    [Abstract] [Full Text] [Related]

  • 4. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.
    Gamble JM, Chibrikov E, Twells LK, Midodzi WK, Young SW, MacDonald D, Majumdar SR.
    Lancet Diabetes Endocrinol; 2017 Jan 22; 5(1):43-52. PubMed ID: 27865756
    [Abstract] [Full Text] [Related]

  • 5. Statin therapy and cardiovascular protection in type 2 diabetes: The role of baseline LDL-Cholesterol levels. A systematic review and meta-analysis of observational studies.
    Soroush N, Nekouei Shahraki M, Mohammadi Jouabadi S, Amiri M, Aribas E, Stricker BH, Ahmadizar F.
    Nutr Metab Cardiovasc Dis; 2024 Sep 22; 34(9):2021-2033. PubMed ID: 38866619
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J, Mehta R, Donnelly R, Idris I.
    Ann Med; 2016 Sep 22; 48(4):224-34. PubMed ID: 26982210
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
    Anyanwagu U, Mamza J, Mehta R, Donnelly R, Idris I.
    Heart; 2016 Oct 01; 102(19):1581-7. PubMed ID: 27217068
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Albuminuria Regression and All-Cause Mortality among Insulin-Treated Patients with Type 2 Diabetes: Analysis of a Large UK Primary Care Cohort.
    Anyanwagu U, Donnelly R, Idris I.
    Am J Nephrol; 2019 Oct 01; 49(2):146-155. PubMed ID: 30677760
    [Abstract] [Full Text] [Related]

  • 15. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V, Kumar A, Patel DR, John JS, Wolski KE, McErlean E, Riesmeyer JS, Weerakkody G, Ruotolo G, Cremer PC, Nicholls SJ, Lincoff AM, Nissen SE.
    J Am Heart Assoc; 2020 Jan 07; 9(1):e014328. PubMed ID: 31852422
    [Abstract] [Full Text] [Related]

  • 16. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
    Chang SH, Wu LS, Lee CH, Kuo CT, Liu JR, Wen MS, Chen WJ, See LC, Yeh YH.
    Int J Cardiol; 2015 Jan 07; 190():20-5. PubMed ID: 25912112
    [Abstract] [Full Text] [Related]

  • 17. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
    Fung CSC, Wan EYF, Chan AKC, Lam CLK.
    BMC Cardiovasc Disord; 2017 Jun 24; 17(1):166. PubMed ID: 28645252
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.
    Mansi IA, English J, Zhang S, Mortensen EM, Halm EA.
    Drug Saf; 2016 Jun 24; 39(6):543-59. PubMed ID: 26979831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.